The office, in Menlo Park, will provide drugmakers in the region with everything from discovery and development to active pharmaceutical ingredient manufacturing (API) services.
Senn's director of project management and client services, Elizabeth Hoffner, predicted that the new office will be important in generating new business for the contract manufacturing organisation (CM).
"We expect our new location, interspersed with many dynamic young companies, and established research institutions including the Stanford and University of California campuses, will allow us to better identify the projects and companies where our expertise can help bring a new compound, therapy or diagnostic method to market more quickly and efficiently."